PTT 007
Alternative Names: PTT-007Latest Information Update: 10 Mar 2024
At a glance
- Originator Pyrotech Therapeutics
- Class Antineoplastics; Small molecules
- Mechanism of Action Pyroptosis modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 20 Feb 2024 Early research in Cancer in China (unspecified route), prior to February 2024 (Pyrotech Therapeutics pipeline, February 2024)